SILBERMAN DAVID (Chief Financial Officer) received a stock award from ORAMED PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/31/2023ACC: 0001209191-23-033141
Officer· Chief Financial Officer
Since Jul 2021
+24.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
24.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+24.50K
Price / share
—
Trade value
—
% of position
11.9%
5/26/2023
205.50K→230K
Total
Net shares
+24.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/26/2023 | A · Award | +24.50K | — | — | 11.9% | 205.50K | 230K |
| Total | +24.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported